Low TREM1 expression in whole blood predicts anti-TNF response in inflammatory bowel disease-Reference-Cited by-同舟云学术

Low TREM1 expression in whole blood predicts anti-TNF response in inflammatory bowel disease

Published:2019-02 Issue: Volume:40 Page:733-742
ISSN:2352-3964
Container-title:EBioMedicine
language:en
Short-container-title:EBioMedicine

Author:

Verstockt Bram,Verstockt Sare,Dehairs Jonas,Ballet Vera,Blevi Helene,Wollants Willem-Jan,Breynaert Christine,Van Assche Gert,Vermeire Séverine,Ferrante Marc

Funder

KU Leuven Research & Development

Research Foundation Flanders

Research and Development

University Hospitals

European Research Council

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference31 articles.

1. Have biologics changed the natural history of Crohn's disease?;Mandel;Dig Dis,2014

2. New treatment options for inflammatory bowel diseases;Verstockt;J Gastroenterol,2018

3. Inflammatory bowel disease: towards a personalized medicine;Flamant;Ther Adv Gastroenterol,2018

4. Novel therapeutic targets for inflammatory bowel disease;Argollo;J Autoimmun,2017

5. Mechanism of action of anti-TNF therapy in inflammatory bowel disease;Levin;J Crohns Colitis,2016

Cited by 133 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of blockage of Trem1 on the M1 polarization of macrophages in the regulation dental pulp inflammation;European Journal of Oral Sciences;2024-09-12

2. Developing a Machine-Learning Prediction Model for Infliximab Response in Crohn’s Disease: Integrating Clinical Characteristics and Longitudinal Laboratory Trends;Inflammatory Bowel Diseases;2024-08-10

3. The Contribution of Genetic and Epigenetic Factors: An Emerging Concept in the Assessment and Prognosis of Inflammatory Bowel Diseases;International Journal of Molecular Sciences;2024-08-01

4. Peripheral blood DNA methylation signatures predict response to vedolizumab and ustekinumab in adult patients with Crohn’s disease: The EPIC-CD study;2024-07-25

5. Biomarkers for Personalizing IBD Therapy: The Quest Continues;Clinical Gastroenterology and Hepatology;2024-07